---
title: "Median Technologies Reports 36.95 Million Shares and 36.88 Million Voting Rights"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275636904.md"
datetime: "2026-02-11T16:45:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275636904.md)
  - [en](https://longbridge.com/en/news/275636904.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275636904.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275636904.md) | [繁體中文](https://longbridge.com/zh-HK/news/275636904.md)


# Median Technologies Reports 36.95 Million Shares and 36.88 Million Voting Rights

Median Technologies SA has disclosed that, as of January 31, 2026, the company has a total of 36,948,314 issued shares. The number of real voting rights, excluding treasury shares, is 36,878,376, while the theoretical number of voting rights, including treasury shares, is 36,925,114. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Median Technologies SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260211372264) on February 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ChinaAMC SSE STAR Biology and Medicine ETF (588130.CN)](https://longbridge.com/en/quote/588130.CN.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)
- [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/en/quote/512290.CN.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/en/quote/510660.CN.md)
- [iShares Global Healthcare ETF (IXJ.US)](https://longbridge.com/en/quote/IXJ.US.md)
- [Direxion Daily S&P Biotech Bull 3X ETF (LABU.US)](https://longbridge.com/en/quote/LABU.US.md)
- [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/en/quote/512010.CN.md)
- [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [ProShares UltraShort Nasdaq Biotech (BIS.US)](https://longbridge.com/en/quote/BIS.US.md)

## Related News & Research

- [Iterum Therapeutics Received Notice of Delisting](https://longbridge.com/en/news/281174211.md)
- [RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 | RNXT Stock News](https://longbridge.com/en/news/281410663.md)
- [07:45 ETPLEOPHARMA, INC. to Present at the Centri Capital Conference in New York](https://longbridge.com/en/news/281012893.md)
- [Telomir seeks FDA approval for Telomir-1 to treat breast cancer](https://longbridge.com/en/news/281346305.md)
- [Io Biotech Inc - Files Voluntary Chapter 7 Bankruptcy Petition On March 31, 2026 - SEC Filing](https://longbridge.com/en/news/281187506.md)